Search research articles
Contact Us
Filters
Showing results (111-120 of 562) with videos related to
Page
of 57
Sort By:
Cancer Research
|
April 1, 1970
Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice
S M Cohen, E Ertürk, G T Bryan
European Urology
|
August 11, 2020
Molecular Subtypes of T1 Bladder Cancer: Biomolecular Characteristics Versus Clinical Utility
Douglas G Ward, Roland Arnold, Richard T Bryan
Journal of the National Cancer Institute
|
August 1, 1976
Comparative carcinogenicity of 5-nitrothiophenes and 5-nitrofurans in rats
S M Cohen, E Ertürk, G T Bryan
Cancer Research
|
September 1, 1970
Production of leukemia and stomach neoplasms in Swiss, RF, BALB-c, and C3H female mice by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide
S M Cohen, E Ertürk, G T Bryan
Cancer Research
|
May 1, 1970
Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice
E Ertürk, S M Cohen, G T Bryan
Nutrition and Cancer
|
January 1, 1981
Protective effect of nicotinamide on bracken fern induced carcinogenicity in rats
A M Pamukcu, U Milli, G T Bryan
Gan
|
August 1, 1977
Carcinogenicity of 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2) fed to female Sprague-Dawley rats
S M Cohen, M Ichikawa, G T Bryan
Translational Andrology and Urology
|
May 21, 2026
<i>PENK</i> methylation and non-invasive bladder cancer detection
Richard T Bryan, Anshita Goel, Douglas G Ward
Cancer Research
|
November 1, 1982
Nitroreductase-mediated metabolic activation of 2-amino-4-(5-nitro-2-furyl)thiazole and binding to nucleic acids and proteins
S Swaminathan, G M Lower, G T Bryan
The American Journal of Clinical Nutrition
|
July 1, 1971
A possible role of urinary metabolites of tryptophan in the heterotopic recurrence of bladder cancer in man
O Yoshida, R R Brown, G T Bryan
Page
of 57
Search research articles
Search
Showing results (111-120 of 562) with videos related to
Sort By:
Page
of 57
Cancer Research
|
April 1, 1970
Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice
S M Cohen, E Ertürk, G T Bryan
European Urology
|
August 11, 2020
Molecular Subtypes of T1 Bladder Cancer: Biomolecular Characteristics Versus Clinical Utility
Douglas G Ward, Roland Arnold, Richard T Bryan
Journal of the National Cancer Institute
|
August 1, 1976
Comparative carcinogenicity of 5-nitrothiophenes and 5-nitrofurans in rats
S M Cohen, E Ertürk, G T Bryan
Cancer Research
|
September 1, 1970
Production of leukemia and stomach neoplasms in Swiss, RF, BALB-c, and C3H female mice by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide
S M Cohen, E Ertürk, G T Bryan
Cancer Research
|
May 1, 1970
Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice
E Ertürk, S M Cohen, G T Bryan
Nutrition and Cancer
|
January 1, 1981
Protective effect of nicotinamide on bracken fern induced carcinogenicity in rats
A M Pamukcu, U Milli, G T Bryan
Gan
|
August 1, 1977
Carcinogenicity of 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2) fed to female Sprague-Dawley rats
S M Cohen, M Ichikawa, G T Bryan
Translational Andrology and Urology
|
May 21, 2026
<i>PENK</i> methylation and non-invasive bladder cancer detection
Richard T Bryan, Anshita Goel, Douglas G Ward
Cancer Research
|
November 1, 1982
Nitroreductase-mediated metabolic activation of 2-amino-4-(5-nitro-2-furyl)thiazole and binding to nucleic acids and proteins
S Swaminathan, G M Lower, G T Bryan
The American Journal of Clinical Nutrition
|
July 1, 1971
A possible role of urinary metabolites of tryptophan in the heterotopic recurrence of bladder cancer in man
O Yoshida, R R Brown, G T Bryan
Page
of 57